SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001654954-21-001900
Filing Date
2021-02-19
Accepted
2021-02-19 15:12:58
Documents
1
Period of Report
2021-02-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 4  
1 PRIMARY DOCUMENT section16.xml 4 14032
  Complete submission text file 0001654954-21-001900.txt   15550
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850 (301) 825 5320
Cellular Biomedicine Group, Inc. (Issuer) CIK: 0001378624 (see all company filings)

IRS No.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 530 UNIVERSITY AVENUE #17 PALO ALTO CA 94301
Business Address
Yao Yihong (Reporting) CIK: 0001651520 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36498 | Film No.: 21654885